Analysis of the regulatory scenario for the renewal of registration of generic and similar drugs at the National Health Surveillance Agency: subsidy to the health regulation of post-registration of drugs. (2020). Health Surveillance under Debate: Society, Science & Technology , 8(1), 4-9. https://doi.org/10.22239/2317-269X.01323